Epstein-Barr Virus and Breast Cancer: Serological Study in a High-Incidence Area of Nasopharyngeal Carcinoma

Jian-Rong He,Lu-Ying Tang,Dan-Dan Yu,Feng-Xi Su,Er-Wei Song,Ying Lin,Shen-Ming Wang,Guan-Chao Lai,Wei-Qing Chen,Ze-Fang Ren
DOI: https://doi.org/10.1016/j.canlet.2011.05.012
IF: 9.756
2011-01-01
Cancer Letters
Abstract:We investigated IgA and IgG levels against EBV viral capsid antigen (VCA) and nuclear antigen-1 (EBNA-1) in serum of 223 women with breast cancer (BC) and 309 controls in Guangzhou, China. VCA IgA levels were significantly associated with an elevated risk of BC, with adjusted ORs (95%CIs) of 1.70 (1.05–2.76) (seropositivity) and 2.21 (1.11–4.40) (unit increases in OD value). This association was stronger among young, lean, and HER2+ women. The EBNA-1 IgA levels in OD value, but not seropositivity, were associated with an increased risk of BC among ER+, PR+, and HER2+ patients. None of the IgG variables was related to BC. These results suggest the EBV association with BC in an endemic area of nasopharyngeal carcinoma.
What problem does this paper attempt to address?